Further, miR-143-3p can be a target to the vasohibin-1 (VASH1) to inhibit its translation, which leads to the hypoubiquitylation of VEGFA to inhibit its degradation and promotes angiogenesis in lung cancer (Wang et al., 2019). Here, VASH1 is linked to lung carcinoma.